homocysteine has been researched along with 8,11,14-eicosatrienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayotunde, A; Hughes, WM; Kumar, M; Metreveli, N; Moshal, KS; Rodriguez, WE; Rosenberger, DS; Sen, U; Singh, M; Sithu, SD; Tyagi, N; Tyagi, SC; Vacek, TP; Zeldin, DC | 1 |
| Chen, Y; Hammock, BD; Kong, W; Xie, X; Zhang, D; Zhu, Y | 1 |
2 other study(ies) available for homocysteine and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cells, Cultured; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Enzyme Activation; Enzyme Induction; Homocysteine; Hyperhomocysteinemia; I-kappa B Proteins; Matrix Metalloproteinase 9; Mice; NF-KappaB Inhibitor alpha; Oxygenases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Transcription Factor RelA; Transfection | 2008 |
Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Activating Transcription Factor 6; Animals; Aorta; Base Sequence; DNA Methylation; Endothelial Cells; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Hyperhomocysteinemia; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Promoter Regions, Genetic; Pyrenes; RNA, Small Interfering; Solubility; Up-Regulation | 2012 |